The Leading Community for Trusted Peptide Research & Insights
Research summaries, dosing protocols, and community reports for peptides. Built on clinical data and real-world experiences.
Cerebrolysin is a porcine brain-derived peptide preparation containing low-molecular-weight neuropeptides and free amino acids. Approved in many countries (not the US) for stroke, traumatic brain injury, and dementia. One of the most studied neuropeptide formulations.
Summary: Provides neurotrophic factor-like activity through a mixture of brain-derived peptides, supporting neuronal survival, synaptic plasticity, and neurogenesis. Mechanisms (reported/proposed across domains): Neuro / cognition • Contains peptides with activity resembling BDNF, GDNF, NGF, and CNTF, supporting neuronal survival and differentiation. • Enhances synaptic plasticity and long-term...
Approved Internationally (Not FDA Approved)
Dose: 10–30 ml IV (daily in clinical trials) · Route: Intravenous (IV) · Intramuscular (IM) · Frequency: 1× daily · Duration: 10–20 days per course